Follow up on the shortage of Propranolol Sandoz 40 mg tablets (propranolol)
Following to the earlier notice on the Shortage of Propranolol Sandoz 40 mg tablets (propranolol) on the Croatian market, the marketing authorisation holder for this product, Sandoz d.o.o. has notified the Agency for Medicinal Products and Medical Devices of the shortage continuation.
The normalisation in the supply chain with Propranolol Sandoz 40 mg tablets is expected in August 2015.
There are other authorised medicinal products from the same therapeutic group with other active substances and all patients who run out of their medicine should consult their doctor about the continuation of the therapy. In case that the therapy with medicines from the same therapeutic group is not applicable, HALMED will for necessary cases, upon wholesalers’ requests authorise enter/import of a medicinal product that is not authorised in Croatia, but contains the same active substance as the medicine affected by the shortage.